Commentary: Reflections on G. M. Lower and colleagues' 1979 study associating slow acetylator phenotype with urinary bladder cancer: meta-analysis, historical refinements of the hypothesis, and lessons learned.
Rothman
Nathaniel
N
Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health/DHHS, Bethesda, MD 20892, USA. rothmann@mail.nih.gov
Garcia-Closas
Montserrat
M
Hein
David W
DW
D000107:Acetylation; D001191:Arylamine N-Acetyltransferase / Q000235:genetics / Q000378:metabolism*; D004781:Environmental Exposure / Q000009:adverse effects; D020022:Genetic Predisposition to Disease / Q000235:genetics; D006801:Humans; D010641:Phenotype; D001749:Urinary Bladder Neoplasms / Q000201:enzymology / Q000453:epidemiology / Q000235:genetics*
D001191:Arylamine N-Acetyltransferase; C478900:NAT2 protein, human